よむ、つかう、まなぶ。
資料２－２ 重篤副作用疾患別対応マニュアル 薬物性口内炎（案） (18 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/shingi2/0000209243_00004.html |
| 出典情報 | 重篤副作用総合対策検討会（第14回 9／15）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
８．引用文献・参考資料
1) Ayangco L, Rogers RS III: Oral manifestations of erythema multiforme. Dermatol
Clin 21: 195-205 (2003)
2) Volcheck GW: Clinical evaluation and management of drug hypersensitivity.
Immunol Allergy Clin North Am, 24: 357-71 (2004)
3) Aurelian L, Ono F, Burnett J: Herpes simplex virus (HSV)-associated erythema
multiforme (HAEM) a viral disease with an autoimmune component. Dermatol Online
J, 9: 1 (2003)
4) 小川 仁, 嶋崎康相, 角 伸博, 藤盛真樹：チオプロニン（チオラ錠®）で天疱瘡様の口
腔粘膜炎を認めた薬疹の１例．第45回日本口腔外科学会北日本支部学術集会（弘前市，
2019.5.18-19）
5) Williams PM, Conklin RJ. Erythema multiforme: a review and contrast from
Stevens-Johnson syndrome/toxic epidermal necrolysis. Dent Clin North Am, 49:
67-76 (2005)
6) Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical
classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome,
and erythema multiforme. Arch Dermatol, 129: 92-6(1993)
7) Habif TP. Hypersensitivity syndromes and vasculitis. In Clinical Dermatology:
A Color Guide to Diagnosis and Therapy. Mosby, 626-34(2004)
8) Leaute-Labreze C, Lamireau T, Chawki D, Maleville J, Taieb A. Diagnosis,
classification, and management of erythema multiforme and Stevens-Johnson
syndrome. Arch Dis Child, 83:347-52(2000)
9) Huff JC. Erythema multiforme and latent herpes simplex infection. Semin Dermatol,
11:207-10(1992)
10) Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC, for
the SCAR Study Group. Severe cutaneous adverse reactions. Correlations between
clinical patterns and causes of erythema multiforme majus, Stevens-Johnson
syndrome, and toxic epidermal necrolysis: results of an international
prospective study. Arch Dermatol, 138:1019-24(2002)
17
1) Ayangco L, Rogers RS III: Oral manifestations of erythema multiforme. Dermatol
Clin 21: 195-205 (2003)
2) Volcheck GW: Clinical evaluation and management of drug hypersensitivity.
Immunol Allergy Clin North Am, 24: 357-71 (2004)
3) Aurelian L, Ono F, Burnett J: Herpes simplex virus (HSV)-associated erythema
multiforme (HAEM) a viral disease with an autoimmune component. Dermatol Online
J, 9: 1 (2003)
4) 小川 仁, 嶋崎康相, 角 伸博, 藤盛真樹：チオプロニン（チオラ錠®）で天疱瘡様の口
腔粘膜炎を認めた薬疹の１例．第45回日本口腔外科学会北日本支部学術集会（弘前市，
2019.5.18-19）
5) Williams PM, Conklin RJ. Erythema multiforme: a review and contrast from
Stevens-Johnson syndrome/toxic epidermal necrolysis. Dent Clin North Am, 49:
67-76 (2005)
6) Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical
classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome,
and erythema multiforme. Arch Dermatol, 129: 92-6(1993)
7) Habif TP. Hypersensitivity syndromes and vasculitis. In Clinical Dermatology:
A Color Guide to Diagnosis and Therapy. Mosby, 626-34(2004)
8) Leaute-Labreze C, Lamireau T, Chawki D, Maleville J, Taieb A. Diagnosis,
classification, and management of erythema multiforme and Stevens-Johnson
syndrome. Arch Dis Child, 83:347-52(2000)
9) Huff JC. Erythema multiforme and latent herpes simplex infection. Semin Dermatol,
11:207-10(1992)
10) Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC, for
the SCAR Study Group. Severe cutaneous adverse reactions. Correlations between
clinical patterns and causes of erythema multiforme majus, Stevens-Johnson
syndrome, and toxic epidermal necrolysis: results of an international
prospective study. Arch Dermatol, 138:1019-24(2002)
17